Acquisition Opportunity TD2 International's acquisition of Flow Contract Site Laboratory expands its preclinical and clinical services, creating a channel to cross sell Flow's GLP and non GLP flow cytometry capabilities to a broader customer base. Position Flow as a specialist for immunophenotyping, receptor occupancy, intracellular cytokine and phospho protein detection, and other flow based assays within TD2's network; pursue joint go to market with TD2 or preferred vendor arrangements.

Niche Flow Cytometry Flow Contract Site Laboratory offers eight color antibody panels and capabilities across whole blood, tissue, frozen PBMCs and tumor samples for preclinical and clinical development. This niche capability aligns with immuno oncology and cellular therapy biomarker programs, presenting sales opportunities with biotech and pharma sponsors requiring deep immunophenotyping and functional assays, including bead based cytokine and HLA antibody testing.

Capacity Flexibility As a small CRO with a compact team and modest revenue, FCSL offers agility and fast turnaround but limited capacity. This makes it an ideal partner for overflow work, pilot studies, or co development engagements within a larger network. Propose scalable engagement models, clear service level agreements, and potential white label or co branded service options to win project based work.

GLP Capabilities FCSL provides both GLP and non GLP flow cytometry services, enabling its use in GLP compliant studies and regulatory submissions alongside traditional research programs. Target sponsors requiring robust immunophenotyping, receptor occupancy, and cellular function data across translational research, with emphasis on immunotherapy and biomarker validation.

Regional Proximity Located in Bothell, Washington near Seattle's biotech cluster, FCSL can leverage regional proximity to West Coast biopharma and academic labs for faster engagement, pilots, and on site collaboration opportunities within a growing CRO ecosystem. Use this regional access to tailor outreach to IO focused startups, CRO networks, and trial sponsors seeking nearby CRO partners.